Case Report

Recently published articles about Case Report

JCP
Administering Semaglutide With Long-Term Olanzapine Use
Case Report

June 9, 2025

This report describes use of the GLP-1R agonist semaglutide in a patient with schizophrenia and severe, olanzapine-induced weight gain that was resistant to alternative treatments.
, , , et al
PCC
β-blocker/Colchicine Coingestion With Cocaine Intoxication
Case Report

June 5, 2025

The authors describe a case in which cocaine-induced cardiac toxicity initially masked β-blocker (carvedilol) toxicity and suggest improvements in management for similar cases.
,
PCC
Excited Catatonia in Opioid and Benzodiazepine Withdrawal
Case Report

June 5, 2025

A 37-year-old man developed excited catatonia in the setting of concurrent opioid and benzodiazepine withdrawal, requiring high dosages of benzodiazepines to resolve.
, ,
PCC
PRES With Obstructive Hydrocephalus
Case Report

May 29, 2025

A man with history of severe hypertension, hyperthyroidism, and cocaine and methamphetamine use presented with severe headache, nausea, dizziness, and bright spots in his left eye.
, , , et al
PCC
Antibiotic-Related Psychotic Episodes in Adolescents
Case Report

May 27, 2025

The authors present a case of first-episode psychosis in a 17-year-old male following amoxicillin administration.
, , , et al
PCC
Prolonged Delirium After ECT
Case Report

May 20, 2025

The authors present a case of prolonged ECT-associated delirium in a 65-year-old woman, offering insights into the proposed pathophysiology.
, , , et al

Recent JCP Articles on Case Report

JCP
What Clinicians Should Know About the Pragmatic Use of Xanomeline-Trospium Combination
ASCP Corner

June 9, 2025

This article will help familiarize clinicians with practical issues in the use of xanomeline-trospium and its entry into the pharmacopoeia for schizophrenia.
,
JCP
The Dopamine-3 Receptor in the Treatment of Schizophrenia: Part 1
Insights

June 6, 2025

In Part I of his video, Dr. Ragy Girgis highlights the D3 receptor as a promising target in schizophrenia, with potential to address negative and cognitive symptoms unmet by...
JCP
The Dopamine-3 Receptor in the Treatment of Schizophrenia: Part 2
Insights

June 6, 2025

In Part II of his video, Dr. Ragy Girgis examines D3 receptor binding by antipsychotics and its potential to improve negative symptoms in schizophrenia.

Recent PCC Articles on Case Report

PCC
Efficacy of GLP-1 Agonists in Mental Disorders
Review Article

June 10, 2025

Current evidence underscores the potential of GLP-1 receptor agonists as a novel therapeutic approach for certain psychiatric disorders, particularly AUDs, depression, and autism-related food behaviors.
, , , et al
PCC
Multimodal Approaches to Pain Management
Rounds in the General Hospital

June 3, 2025

Although the primary objective of managing acute pain is to provide effective pain relief, it is also important to minimize medication side effects, improve patient function, and reduce the...
, , , et al
PCC
Psychiatric Adverse Effects of Hydroxychloroquine
Systematic Review

May 29, 2025

Hydroxychloroquine use is associated with various neuropsychiatric adverse effects, cognitive impairments, and behavioral changes.
, , , et al

Featured Case Report Research

Physician End-of-Life Preferences Expose Stark Differences
news

June 10, 2025

Research reveals that while most physicians prefer end-of-life comfort over life-extending measures for themselves, their views vary widely.
How Patients Talk May Matter More Than What They Say
news

June 9, 2025

A new study suggests that subtle language cues in how patients talk about their mental health may reveal critical, often overlooked insights.
Restrictive Diets Could Make Depression Worse
news

June 6, 2025

Restrictive diets could make depressive symptoms worse, suggesting that one-size-fits-all eating plans could carry hidden mental health risks.

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe